Blood Group and Disease Associations
Date:
1. ABO Blood Group and Disease Associations
(1) Cardiovascular Diseases
Blood type A: multiple studies have found that people with type A blood have an approximately 5-10% higher risk of developing coronary artery disease than those with type O blood (Meta-analysis, BMC Medicine, 2012). Possible mechanism: individuals with type A blood have higher levels of von Willebrand factor, a coagulation-related protein, which promotes thrombosis.
Blood type O: the risk is lower, but people with type O blood are more prone to hemorrhagic diseases (such as gastric ulcers), which may be related to gastric acid secretion and susceptibility to Helicobacter pylori.
(2) Cancer
Blood type A: the risk of gastric cancer is higher (PLoS One, 2014), which may be related to the modification of ABO glycosyltransferase affecting the colonization of Helicobacter pylori.
Blood type O: the risk of pancreatic cancer is lower (Journal of the National Cancer Institute, 2009), and the risk increases by approximately 20%–30% in people with non-O blood types.
(3) Infectious Diseases
Blood type O: more susceptible to norovirus infection (some strains bind to host cells via blood group antigens). Lower risk of severe malaria (type O red blood cells are less easily infected by Plasmodium, Nature, 2015).
Blood type AB: some studies suggest that the risk of severe COVID-19 may be higher (Blood Advances, 2021), but the conclusion is still controversial.
(4) Others
- Blood type B: the risk of type 2 diabetes may be slightly higher (Diabetologia, 2015), but the mechanism remains unclear.
2. Rh Blood Group and Diseases
Rh-negative: Pregnancy-related risks (such as fetal hemolytic disease), but the association with chronic diseases is weak. A small number of studies suggest that Rh-negative people may be more likely to develop certain autoimmune diseases (such as Sjögren’s syndrome), which requires further verification.
3. Mechanistic Explanation
(1) Molecular mechanism: ABO antigens affect cell signaling, adhesion and inflammatory responses, for example: (a) ABO glycosyltransferase may modify other proteins (such as endothelin-1) and affect vascular function; (b) blood group antigens alter the composition of gut microbiota, indirectly affecting the risk of metabolic diseases.
(2) Evolutionary hypothesis: certain blood types were retained by natural selection in areas with specific epidemic infectious diseases (e.g., type O in malaria-endemic regions).
4. Notes
(1) Correlation ≠ Causation: most studies are epidemiological statistics, and more mechanistic research is needed.
(2) Other factors are dominant: the influence of blood type is usually small, far lower than that of traditional risk factors such as smoking and obesity.
(3) Individual differences: blood type is only one of many genetic and environmental factors, and cannot be used alone for disease prediction.
5. Conclusion
The association between blood type and disease has scientific basis, but its practical clinical significance is limited. Future studies may reveal more specific molecular mechanisms and facilitate personalized medicine. It is recommended that people focus on controllable risk factors such as diet and exercise, rather than worrying excessively about the influence of blood type.
6. References
- Franchini, M., & Lippi, G. (2012). BMC Medicine, 10, 129. DOI: 10.1186/1741-7015-10-129
- Edgren, G., et al. (2014). PLoS One, 9(1), e84887. DOI: 10.1371/journal.pone.0084887
- Wolpin, B. M., et al. (2009). Journal of the National Cancer Institute, 101(6), 424–431. DOI: 10.1093/jnci/djp020
- Rowe, J. A., et al. (2015). Nature, 526(7572), 253–257. DOI: 10.1038/nature15373
- Zietz, M., & Tatonetti, N. P. (2021). Blood Advances, 5(7), 1301–1309. DOI: 10.1182/bloodadvances.2020004011
- Fagherazzi, G., et al. (2015). Diabetologia, 58(3), 519–522. DOI: 10.1007/s00125-014-3472-9